Global Stented Biological Valve Market Strategic Research Report

Scope of the Report

The global Stented Biological Valve market size is predicted to grow from US$ 3,301 million in 2025 to US$ 4,862 million in 2032; it is expected to grow at a CAGR of 5.8% from 2026 to 2032.

In 2024, global stented biological valve production reached approximately 115 K units, with an average global market price of around US$ 26,392 per unit and a gross profit margin of approximately 50%-80%.

A stented biological valve is a type of bioprosthetic heart valve that incorporates a metallic or polymeric stent to hold the valve in place. These valves are made from animal tissues (bovine or porcine) and are designed for patients who require a valve replacement but do not wish to take long-term anticoagulants.

Market Overview:

Stented biological valves are among the most commonly used valves in heart valve replacement surgeries. They are widely used due to their natural function, low risk of thromboembolic events, and favorable clinical outcomes. The addition of a stent allows for easier implantation, particularly in older patients and those undergoing transcatheter procedures.

Market Drivers:

Preference for biological valves over mechanical valves due to their natural function and reduced need for anticoagulation.

Increasing adoption of minimally invasive approaches like TAVR, where stented biological valves are often preferred.

Aging populations and the rising incidence of valvular heart disease.

Market Opportunities:

Expanding indications for the use of stented biological valves in various procedures, particularly in lower-risk patient populations.

Research into improving the longevity and anti-calcification properties of stented valves.

Market Limitations:

Limited durability compared to mechanical valves, which may require reoperation in younger patients.

Concerns about the risk of degeneration and calcification, particularly in patients under 65 years old.

Market Trends:

Greater adoption of TAVR procedures, leading to a rise in the use of stented biological valves.

Ongoing improvements in the durability and biocompatibility of stented biological valves.

This report presents a comprehensive overview of the global Stented Biological Valve market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Surgical Valve
• Interventional Valve

Segment by Application

• Hospital
• Clinic
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Stented Biological Valve market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinic, Other evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact